Taiwan FDA registration 2c3d23f038754e754867cae0a158f41e
"Hannitec" removes the whole blood collection system for white blood cells
TW: “漢尼帝克”去除白血球全血收集系統
Taiwan·Risk Class 2·Haemonetics Manufacturing, Inc.·Registered Nov 25, 2011 – Nov 25, 2021CancelledRegistration details
- Analysis ID
- 2c3d23f038754e754867cae0a158f41e
- Customs Code
- DHA00602293600
Company information
- Manufacturer
- Haemonetics Manufacturing, Inc.
- Manufacturer Country
- United States
- Authorized Representative
- HAEMONETICS ASIA INCORPORATED TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9245 Automated hemocytoseparator
- Import Information
- import
Dates and status
- Registration Date
- Nov 25, 2011
- Expiry Date
- Nov 25, 2021
- Cancellation Date
- Oct 12, 2023
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for "Hannitec" removes the whole blood collection system for white blood cells in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2c3d23f038754e754867cae0a158f41e and manufactured by Haemonetics Manufacturing, Inc.. The authorized representative in Taiwan is HAEMONETICS ASIA INCORPORATED TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices